The P2X7 receptor: a main player in inflammation

E Adinolfi, AL Giuliani, E De Marchi, A Pegoraro… - Biochemical …, 2018 - Elsevier
Damage associated molecular patterns (DAMPs) are intracellular molecules released from
infected or injured cells to activate inflammatory and reparatory responses. One of the most …

The P2X7 receptor: central hub of brain diseases

R Andrejew, Á Oliveira-Giacomelli… - Frontiers in Molecular …, 2020 - frontiersin.org
The P2X7 receptor is a cation channel activated by high concentrations of adenosine
triphosphate (ATP). Upon long-term activation, it complexes with membrane proteins forming …

Astrocytes as guardians of neuronal excitability: mechanisms underlying epileptogenesis

QP Verhoog, L Holtman, E Aronica… - Frontiers in …, 2020 - frontiersin.org
Astrocytes are key homeostatic regulators in the central nervous system and play important
roles in physiology. After brain damage caused by eg, status epilepticus, traumatic brain …

Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder

K Recourt, P de Boer, P van der Ark, H Benes… - Translational …, 2023 - nature.com
JNJ-54175446 is a selective purine P2X7 receptor (P2X7R) antagonist that attenuates
microglial IL-1β/IL-18 release. In healthy volunteers, JNJ-54175446 suppressed peripheral …

Medicinal chemistry of adenosine, P2Y and P2X receptors

KA Jacobson, CE Müller - Neuropharmacology, 2016 - Elsevier
Pharmacological tool compounds are now available to define action at the adenosine (ARs),
P2Y and P2X receptors. We present a selection of the most commonly used agents to study …

P2X7 in cancer: from molecular mechanisms to therapeutics

R Lara, E Adinolfi, CA Harwood, M Philpott… - Frontiers in …, 2020 - frontiersin.org
P2X7 is a transmembrane receptor expressed in multiple cell types including neurons,
dendritic cells, macrophages, monocytes, B and T cells where it can drive a wide range of …

The microglial ATP‐gated ion channel P2X7 as a CNS drug target

A Bhattacharya, K Biber - Glia, 2016 - Wiley Online Library
Based on promising preclinical evidence, microglial P2X7 has increasingly being
recognized as a target for therapeutic intervention in neurological and psychiatric diseases …

Involvement of P2X7 receptors in chronic pain disorders

WJ Ren, P Illes - Purinergic Signalling, 2022 - Springer
Chronic pain is caused by cellular damage with an obligatory inflammatory component. In
response to noxious stimuli, high levels of ATP leave according to their concentration …

Discovery of potent cholinesterase inhibition-based multi-target-directed lead compounds for synaptoprotection in Alzheimer's disease

B Turgutalp, P Bhattarai, T Ercetin, C Luise… - Journal of medicinal …, 2022 - ACS Publications
Drug development efforts that focused on single targets failed to provide effective treatment
for Alzheimer's disease (AD). Therefore, we designed cholinesterase inhibition (ChEI) …

Purinergic mechanisms in neuroinflammation: an update from molecules to behavior

E Beamer, F Gölöncsér, G Horváth, K Bekő… - …, 2016 - Elsevier
The principle functions of neuroinflammation are to limit tissue damage and promote tissue
repair in response to pathogens or injury. While neuroinflammation has utility …